Schizophrenia, monoamine oxidase activity, and cigarette smoking

Neuropsychopharmacology

Volumn 20, Issue 4, 1999, Pages 392-394

  Simpson, George M ^a   Shih, Jean C ^a,b   Chen, Kevin ^a   Flowers, Calvin ^a   Kumazawa, Takachi ^a   Spring, Bruce ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cigarettes; Monoamine oxidase; Schizophrenia; Schizophrenia markers; Smoking

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BIOCHEMICAL MARKER;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; BIOLOGICAL MARKERS; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MONOAMINE OXIDASE; SCHIZOPHRENIA; SMOKING;

EID: 0033014548     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00119-5     Document Type: Article

References (17)

1. Berlin I., Saïd S., Spreux-Varoquaux O., Olivares R., Launay J.-M., Puech A.J. Monoamine oxidase A and B activities in heavy smokers. Biol Psychiatry. 38:1995;756-761.
2. Berlin I., Spreux-Varoquaux O., Saïd S., Launay J.-M. Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers. Drug and Alcohol Dependence. 45:1997;31-37.
3. Chen K., Wu H.-F., Shih J.C. Cloning of a novel monamine oxidase (MAO) c DNA from trout liver. Mol Pharm. 46:1994;1226-1233.
4. de Leon J., Dadvand M., Canuso C., White A.O., Stanilla J.K., Simpson G.M. Schizophrenia and smoking. An epidemiologic survey in a state hospital Am J Psychiatry. 152:1995;453-455.
5. de Leon J. Smoking and vulnerability for schizophrenia. Schizophrenia Bulletin. 22(3):1996;405-409.
6. Fleissner A., Seifert R., Schneider K., Eckert W., Fuisting B. Platelet monoamine oxidase activity and schizophrenia - A myth that refuses to die? Eur Arch Psychiatr Neurol Sci. 237:1987;8-15.
7. Fowler J.S., Volkow N.D., Wang G.-J., Pappas N., Logan J., MacGregor R., Alexoff D., Shea C., Schlyer D., Wolf A.P., Warner D., Zezulkova I., Cilento R. Inhibition of monamine oxidase B in the brains of smokers. Nature. 379:1996;733-736. a.
8. Fowler J.S., Volkow N.D., Wang G.-J., Pappas N., Logan J., Shea C., Alexoff D., MacGregor R.R., Schlyer D.J., Zezulkova I., Wolf A.P. Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci. 93:1996;14065-14069. b.
9. Glassman A.H. Cigarette smoking. implications for psychiatric illness Am J Psychiatry. 150:1993;546-553.
10. Leonard S., Adams C., Breese C.R., Adler L.E., Bickford P., Byerley W., Coon H., Griffith J.M., Miller C., Myles-Worsley M., Nagamoto H.T., Rollins Y., Stevens K.E., Waldo M., Freedman R. Nicotinic receptor function in schizophrenia. Schizophrenia Bulletin. 22(3):1996;431-445.
11. Marcolin M.A., Davis J.M. Platelet monoamine oxidase activity in schizophrenia. A meta-analysis Schizophrenia Research. 7:1992;249-267.
12. Mendez-Alvarez E., Soto-Otero R., Sànchez-Sellero I., Lamas M. Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke. Life Sciences. 60(19):1997;1719-1727.
13. Murphy D.L., Wyatt R.J. Reduced monoamide oxidase activity in blood platelets from schizophrenic patients. Nature. 238:1972;225.
14. Oreland L., Fowler C.J., Schalling D. Low platelet monoamine oxidase activity in cigarette smokers. Life Science. 29:1981;2511-2518.
15. Wyatt R.J., Murphy D., Belmaker R., Cohen S., Donnelly C.H., Pollin W. Reduced Monoamine Oxidase Activity in Platelets. A Possible Genetic Marker for Vulnerability to Schizophrenia Science. 179:1973;916-918.
16. Wyatt RJ, Potkin SG, Murphy DL (1979): Platelet monoamine oxidase activity in schizophrenia: A review of the data. Am J Psychiatry 136:4A:377-385.
17. Ziedonis D.M., Kosten T.R., Glazer W.M., Frances R.J. Nicotine dependence and schizophrenia. Hosp and Comm Psychiatry. 45:1994;204-206.